Physician profile
Matthew Paul Spittler
NPI 1710516927
$9,960.35
in general payments reported to CMS, 2019-2025
11 companies · $5,334 in 2025
The $5,334 reported for 2025 was more than what 83% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $805 · 2021: $1,220 · 2022: $124 · 2023: $870 · 2024: $1,608 · 2025: $5,334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,299 · Travel and Lodging: $3,512.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,299.16 |
| Travel and Lodging | $3,512.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exactech, INC. | $3,077.24 | 2025 | |
| Stryker Corporation | $2,479.40 | 2022-2025 | Mako, Triathlon, Accolade |
| Rock Medical Orthopedics, INC. | $2,172.55 | 2020-2024 | |
| Arthrex, INC. | $1,079.11 | 2025 | |
| Smith+Nephew, INC. | $614.56 | 2023-2025 | Evos, Trigen Intertan, Aetos Shoulder System |
| Alliance Medical | $193.80 | 2025 | |
| Abanza INC. | $121.10 | 2025 | Washercap Fixation System 10mm, Washercap Mini Fixation System 4.5mm |
| Depuy Synthes Sales INC. | $110.38 | 2025 | Na, Actis, Motoband |
| Acumed LLC | $49.66 | 2022 | |
| Zimmer Biomet Holdings, INC. | $45.17 | 2024 | Comprehensive Shoulder System |
| Boston Scientific Corporation | $17.38 | 2025 | Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Spittler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.